SRC
CVET

Shufro Rose & Co’s Covetrus, Inc. Common Stock CVET Stock Holding History

Shufro Rose & Co’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,000
Closed -$36K – 353
2019
Q3 		$36K Hold
3,000
– – ﹤0.01% 317
2019
Q2 		$73K Buy
+3,000
New +$86.4K 0.01% 294

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Shufro Rose & Co's CVET Position: Q3 2022 in Review

Shufro Rose & Co sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2022, closing a stake of 12,100 shares — an estimated $251K sold.

Shufro Rose & Co first reported a position in CVET in Q2 2019 and held it in 13 quarters. The position peaked at $665K in Q3 2020. 250 funds tracked by Wall St. Rank hold CVET as of Q3 2022.

  • Shufro Rose & Co reported no remaining Covetrus, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Shufro Rose & Co sold 12,100 Covetrus, Inc. Common Stock shares in Q3 2022, an estimated $251K.
  • Shufro Rose & Co first reported a position in Covetrus, Inc. Common Stock in Q2 2019 and held it in 13 quarters.
  • Shufro Rose & Co's Covetrus, Inc. Common Stock position peaked at $665K in Q3 2020.
  • 250 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2022.

Based on Shufro Rose & Co's 13F filing for Q3 2022, filed 24 Oct 2022.